NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-047-2021-0-MX-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF MX National Stage MX/a/2023/006938 Pending
NLM E-111-2022-2-PC-01 ECHOCARDIOGRAPHIC ESTIMATION OF RIGHT ATRIAL PRESSURE USING A LIGHTWEIGHT AND OPEN-WORLD ARTIFICIAL INTELLIGENCE SYSTEM PCT PCT COMB PCT/US2023/024902 Expired
NCI E-147-2021-0-US-02 COMPOSITIONS AND METHODS FOR TREATING CANCER US National Stage 18/266,455 Pending
NIEHS E-184-2023-0-US-01 METHOD AND APPARATUS FOR CRYOGENIC-ELECTRON MICROSCOPY SAMPLE PREPARATION US 63/472,113 Expired
NCATS E-047-2021-0-CA-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CA National Stage 3201841 Pending
NCI E-121-2022-0-PC-01 COMPOSITIONS, SYSTEMS, AND METHODS FOR DELIVERY OF THERAPEUTICS PCT PCT PCT/US2023/068139 Expired
NHLBI E-197-2020-0-EP-01 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING EP National Stage 21892742.4 Pending
NCATS E-046-2021-0-CA-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF CA National Stage 3201690 Pending
NIAID E-057-2011-2-US-07 VIRUS-LIKE PARTICLES AND METHODS OF USE US DIV 18/331,083 12168675 Issued PDF
NCATS E-156-2022-0-PC-01 COMPOUNDS FOR INHIBITING GRAM-POSITIVE BACTERIA PCT PCT PCT/US2023/068040 Expired
NIDDK E-160-2022-0-PC-01 COMPOSITIONS AND METHODS FOR PHARMACOLOGIC TREATMENT OF STROKE AND MYOCARDIAL ISCHEMIA REPERFUSION INJURY PCT PCT PCT/US2023/024676 Expired
NCI E-013-2018-0-US-04 Compositions and Methods for Treating Cancer with Anti-CD19 Immunotherapy US DIV 18/330,587 Pending
NCATS E-006-2022-0-PC-01 LATS INHIBITORS AND USES THEREOF PCT PCT PCT/US2023/024589 Expired
NCI E-186-2022-0-PC-01 PREDICTING PATIENT RESPONSE TO CANCER THERAPY VIA HISTOPATHOLOGY IMAGES PCT PCT PCT/US2023/024571 Expired
NCI E-074-2020-1-HK-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION HK EP 62023074121.2 Pending
NCI E-031-2020-0-HK-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12D MUTATION HK EP 62023074114.7 Pending
NCI E-231-2020-0-EP-02 METHOD OF SELECTING T CELLS WITH IMPROVED ANTI-CANCER ACTIVITY EP National Stage 21801948.7 Pending
NCI E-176-2014-0-JP-01 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS JP DIV 2023-091878 Issued
NIAID E-193-2021-0-PC-01 ENGINEERED CELL-PENETRATING ANTIVIRAL COMPOUND PCT PCT PCT/US2023/067856 Expired
NIAID E-137-2018-2-JP-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response JP DIV 2023-091864 Pending
NIAID E-118-2023-2-US-01 VACCINE FOR CATS TO BLOCK TOXOPLASMA OOCYST SHEDDING AND TRANSMISSION US 63/470,773 Expired
NCI E-067-2017-0-EP-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES EP DIV 23176735.1 Pending
NIAID E-093-2022-0-PC-01 COMPOSITIONS AND METHODS FOR DETECTING LYMPHATIC FILARIASIS PCT PCT PCT/US2023/067703 Expired
NCI E-167-2017-0-JP-01 NOVEL CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY JP DIV 2023-090523 Abandoned
NCI E-180-2023-0-US-01 Method for manufacturing TCR-T cell therapy products targeting tumor antigen(s) from patients with HIV and cancer US 63/469,641 Expired
NIAID E-169-2023-0-US-01 HIV-1 Envelope Triple Tandem Trimers US 63/469,773 Expired
NIDCR E-011-2023-0-US-01 COPIPARVOVIRUS GENETIC VECTOR PLATFORM US 63/469,337 Expired
NCI E-495-2013-0-US-02 ANTI-HUMAN PAPILLOMAVIRUS 16 E6 T CELL RECEPTORS US CON 18/323,493 12187779 Issued PDF
NEI E-116-2023-0-US-01 TYROSINASE GENE THERAPY FOR OCULOCUTANEOUS ALBINISM TYPE 1A US 63/468,748 Expired
NIAID E-014-2023-0-US-01 HUMAN MONOCLONAL ANTIBODIES THAT TARGET THE RH5 COMPLEX OF BLOOD-STAGE PLASMODIUM FALCIPARUM US 63/468,740 Expired
NCI E-202-2020-0-AU-01 TYROSYL-LOCK PEPTIDES AU National Stage 2021385049 Pending
NCI E-099-2023-1-US-01 T CELL RECEPTORS (TCRS) GENERATED AS A RESULT OF HPV VACCINE THERAPY AND METHODS OF TREATING PATIENTS WITH SAME US 63/503,578 Expired
NIAID E-103-2022-0-PC-01 Replicating RNA Vaccine For Crimean-Congo Hemorrhagic Fever Virus PCT PCT PCT/US2023/067226 Expired
NIAID E-021-2021-0-US-02 NOVEL VAR2CSA IMMUNOGENS AND METHODS OF USE THEREOF US National Stage 18/037,837 Pending
NCI E-086-2012-2-US-11 Methods for Generation of Pluripotent and Multipotent Cells US CON 18/320,244 Abandoned
NHLBI E-005-2021-0-EP-01 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE EP National Stage 21830819.5 Pending
NCI E-172-2022-0-PC-01 SMALL CELL LUNG CANCER SUBTYPING USING PLASMA CELL-FREE NUCLEOSOMES PCT PCT PCT/IL2023/050509 Expired
NCI E-202-2020-0-US-02 TYROSYL-LOCK PEPTIDES US National Stage 18/037,379 Pending
NIAID E-240-2020-0-US-01 RECOMBINANT MURINE PNEUMONIA VIRUS EXPRESSING SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE PROTEIN US 63/502,829 Expired
NCI E-202-2020-0-CA-01 TYROSYL-LOCK PEPTIDES CA National Stage 3199368 Pending
NCI E-099-2014-0-US-02 USES OF MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS US CON 18/318588 Pending
NCI E-171-2020-0-EP-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection EP National Stage 21851911.4 Pending
NCATS E-234-2020-0-US-02 Small Molecule Inhibitors of Sars-Cov-2 Infections US National Stage 18/253,031 Pending
NICHD E-003-2014-0-US-02 MONOCLONAL ANTIBODIES THAT SPECIFICALLY BIND TO MATRILIN 3 AND THEIR USE US CON 18/317,869 Abandoned
NIBIB E-007-2021-0-EP-01 ANTIBODY SPECIFIC FOR SARS]COV]2 RECEPTOR BINDING DOMAIN AND THERAPEUTIC METHODS EP National Stage 21802499.0 Abandoned
NLM E-125-2017-2-JP-01 CRYSTAL STRUCTURE OF CRISPR CPF1 JP DIV 2023-079002 Issued
NCI E-094-2022-0-PC-01 PIM-TARGETED PROTACS WITH PIM-BINDING MOIETIES SGI-1776, AZD-1208 OR PIM-447, AND A E3 UBIQUITIN LIGASE BINDING MOIETY FOR THE TREATMENT OF CANCER PCT PCT PCT/US2023/022017 Expired
NCI E-129-2023-0-US-01 SINGLE DOMAIN ANTIBODIES THAT SPECIFICALLY BIND THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN AND COMPOSITIONS AND USES THEREOF US 63/501,772 Expired
NCATS E-026-2016-0-CA-01 Compounds for Improving MRNA Splicing CA DIV 3199430 Abandoned
NIAID E-137-2018-2-IL-01 Peptide-based Vaccines, Methods Of Manufacturing, And Uses Thereof For Inducing An Immune Response IL DIV 302880 Pending